The current evidence for the administration of intramuscular influenza vaccines suggests there is no significant difference in safety and clinical effectiveness with the use of lowdose compared to full - dose vaccines , which is promising given the predicted resource constraints in the upcoming influenza season due to the 2019 novel coronavirus .